drugset / Trial / NCT01001988

Long-term Follow-up of Immunogenicity of a Single Dose of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Toddlers

NCT01001988 ↗

Phase 3 Completed 596 enrolled Sanofi Pasteur, a Sanofi Company
NaSingle-groupOpen-labelPrevention

Summary

This is a long-term follow-up of the persistence of immune response in participants who previously received a single dose of JE-CV at age 12 to 18 months in Study JEC02 (NCT00735644) . No vaccination was administered during the present long-term follow-up study. Primary Objective: * To describe the yearly persistence of humoral immune response to Japanese encephalitis after a single dose of JE-CV

Timeline

Start
2009-08-07
Primary completion
2013-10-16
Completion
2013-10-16

Drugs

EvaluationDrugModalityDoseRoute
Subject Japanese Encephalitis Chimeric Virus Vaccine Vaccine — —

Indications